Composition
- Active ingredients
- INFLIXIMAB-ABDA 100MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761054.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Renflexis
- Active substance
- infliximab-abda
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Samsung Bioepis Co LTD
- Status
- Prescription
- FDA approval
- 21 Apr 2017
- Application
- BLA761054-001